| 000 | 01606 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516071613.0 | ||
| 264 | 0 | _c20120403 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1750-1172 | ||
| 024 | 7 |
_a10.1186/1750-1172-6-86 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBouazza, Naïm | |
| 245 | 0 | 0 |
_aPopulation pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients. _h[electronic resource] |
| 260 |
_bOrphanet journal of rare diseases _cDec 2011 |
||
| 300 |
_a86 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCysteamine _xadministration & dosage |
| 650 | 0 | 4 |
_aCystine _xblood |
| 650 | 0 | 4 |
_aCystinosis _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFanconi Syndrome |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aRadiation-Protective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aTréluyer, Jean-Marc | |
| 700 | 1 | _aOttolenghi, Chris | |
| 700 | 1 | _aUrien, Saik | |
| 700 | 1 | _aDeschenes, Georges | |
| 700 | 1 | _aRicquier, Daniel | |
| 700 | 1 | _aNiaudet, Patrick | |
| 700 | 1 | _aChadefaux-Vekemans, Bernadette | |
| 773 | 0 |
_tOrphanet journal of rare diseases _gvol. 6 _gp. 86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1750-1172-6-86 _zAvailable from publisher's website |
| 999 |
_c21416108 _d21416108 |
||